Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:05:30.892Z.
Calculation as of: 2026-10-06T12:05:30.892Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 66e3eaee1cdd755dffe0dd2f4d89b3fc137545160e5faabf240127d9674bae42
EARNINGS YIELD
N/A
Market Cap
$192.97M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$184.12M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$179.70M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$174.17M
Earnings Yield
N/A
TTM Avg
12.15%
3Y Avg
12.15%
5Y Avg
12.15%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | $202.05M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $218.42M | 16.25% | 15.50% | 9.57% | 9.57% |
| Journey Medical Corporation (DERM)vs › | $184.12M | N/A | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $220.94M | N/A | 3.98% | 3.98% | 3.98% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | N/A | 12.15% | 12.15% | 12.15% |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | N/A | 18.91% | 18.91% | 12.56% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
